[Whole-body hyperthermia and hyperglycemia in the combined treatment of rectal cancer].

The paper is concerned with the results of combined therapy of 210 rectal cancer patients (stage III1 using hyperthermia, hyperglycemia and monochemotherapy (5-FU), and 6 patients with metastatic liver cancer who received intraportal chemotherapy. A selective damaging effect of hyperglycemia on a tumor cell was revealed. The use of hyperglycemia-hyperthermia-chemotherapy in the preoperative period was substantiated, the 3-year survival of 69 patients who had received single sessions of hyperthermia-hyperglycemia-monochemotherapy, was 77%. Positive results of intraportal administration of 5-FU were noted in the patients with metastatic liver cancer.